Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
1.090
+0.010 (0.93%)
At close: Nov 20, 2024, 4:00 PM
1.260
+0.170 (15.60%)
Pre-market: Nov 21, 2024, 6:54 AM EST
Cue Biopharma Employees
Cue Biopharma had 53 employees as of December 31, 2023. The number of employees increased by 1 or 1.92% compared to the previous year.
Employees
53
Change (1Y)
1
Growth (1Y)
1.92%
Revenue / Employee
$179,849
Profits / Employee
-$841,736
Market Cap
65.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InterCure | 270 |
Celularity | 120 |
AlloVir | 112 |
ALX Oncology Holdings | 72 |
electroCore | 68 |
InspireMD | 66 |
BeyondSpring | 36 |
CUE News
- 6 days ago - Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 7 days ago - Cue Biopharma Announces Strategic Organizational Transition - GlobeNewsWire
- 12 days ago - Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting - GlobeNewsWire
- 6 weeks ago - Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting - GlobeNewsWire
- 7 weeks ago - Cue Biopharma Announces Pricing of $12.0 Million Public Offering - GlobeNewsWire
- 7 weeks ago - Cue Biopharma Announces Proposed Public Offering - GlobeNewsWire
- 2 months ago - Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer - GlobeNewsWire
- 3 months ago - Cue Biopharma, Inc. (CUE) Q2 2024 Earnings Call Transcript - Seeking Alpha